Agios Pharmaceuticals (United States)
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Agios Pharmaceuticals (United States), United States, covering academic research published from 2009 to 2024. Read More.
Open Access Percentage
47%
Total
Publications
583
Total Open
Publications
276
Total
Citations
45K
Open Access
Percentage
47%
Total
Publications
583
Total Open
Publications
276
Total
Citations
45K
Breakdown
Publisher Open
12%
Both
25%
Other Platform Open
10%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 46%
98
Hybrid 19%
39
No Guarantees 35%
75
Other Platform Open
Domain 77%
160
Other Internet 19%
40
Institution 13%
27
Preprint 6%
12
Public 1%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 162 |
DOI | Other Internet | 38 |
bioRxiv | Preprint | 11 |
Royal Netherlands Academy of Arts and Sciences | Institution | 6 |
Unknown Repository | Other Internet | 5 |
Europe PMC | Domain | 4 |
Office of Scientific and Technical Information | Institution | 3 |
Harvard University | Institution | 3 |
Washington University in St. Louis | Institution | 2 |
Utrecht University | Institution | 2 |